Pentagon posts guidance for mandatory testosterone screening. Here's what it may mean

The Pentagon has released new guidelines addressing mandatory testosterone deficiency screening for male service members over the age of 30 who are currently in active duty or reserve status. This announcement comes two weeks after the temporary withdrawal of similar screening guidelines from the Department of Defense website. The new guidelines aim to establish uniform screening and treatment procedures across the Department of Homeland Security (DHA) enterprise, with a focus on identifying and treating suboptimal hormone levels to enhance service members' overall health, performance, and readiness.

The screening process for male service members will involve a structured symptom and risk assessment, as well as blood tests measuring testosterone levels on two separate mornings while fasting. Additionally, an LH/FSH blood panel will be conducted to assess reproductive hormones. When total testosterone levels fall within a normal range, free testosterone measurements will also be performed. The guidelines emphasize that for service members with normal testosterone levels, these additional tests will be conducted.

For female service members, the Pentagon is reviewing their screening guidelines, which will be posted upon approval. Earlier this year, a top Pentagon adviser clarified that the initially posted document was a draft that had been inadvertently made public. The new screening guidelines come amid growing concern over low testosterone levels in the military, particularly within the special operations community, where intense physical demands and inadequate nutrition may negatively impact hormone levels. Research on this subject is still ongoing.

To put the issue in perspective, between 4.0 million and 13.8 million men in the United States have testosterone deficiency, according to the American Urological Association (AUA). However, the exact scope of the problem remains uncertain, as there are differing thresholds for diagnosing testosterone deficiency. Testosterone issues are most common among older men, those with diabetes or obesity.

Some experts worry that the widespread online discussion surrounding "low-T" could create a false impression of the problem's magnitude, as up to 25% of men who receive testosterone therapy do not have their levels properly tested, and up to one-third of men who receive therapy do not meet medical criteria for a diagnosis.